These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33882341)

  • 1. Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke.
    Mowla A; Sharifian-Dorche M; Mehla S; Lail NS; Sharifian-Dorche A; Vaughn CB; Sawyer RN; Shirani P
    J Neurol Sci; 2021 Jun; 425():117451. PubMed ID: 33882341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis.
    Kamal H; Mehta BK; Ahmed MK; Kavak KS; Zha A; Lail NS; Shirani P; Al-Mufti F; Sawyer RN; Mowla A
    J Neurol Sci; 2021 Jan; 420():117265. PubMed ID: 33333324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic Thrombolysis.
    Mowla A; Shah H; Lail NS; Vaughn CB; Shirani P; Sawyer RN
    Cerebrovasc Dis; 2020; 49(5):503-508. PubMed ID: 32927457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for symptomatic intracranial hemorrhage after intravenous thrombolysis with acute ischemic stroke within 6 h in northern China: a multicenter, retrospective study.
    Xue Y; Li S; Xiang Y; Wang Z; Wang F; Yu Y; Yan P; Liu X; Sun Q; Du Y; Li J
    BMC Neurol; 2022 Jan; 22(1):6. PubMed ID: 34980004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IV Thrombolysis vs Early Dual Antiplatelet Therapy in Patients With Mild Noncardioembolic Ischemic Stroke.
    Sykora M; Krebs S; Miksova D; Badic I; Gattringer T; Fandler-Höfler S; Marko M; Greisenegger S; Knoflach M; Lang W; Ferrari J;
    Neurology; 2023 Aug; 101(9):e933-e939. PubMed ID: 37407270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis.
    Tsivgoulis G; Katsanos AH; Zand R; Sharma VK; Köhrmann M; Giannopoulos S; Dardiotis E; Alexandrov AW; Mitsias PD; Schellinger PD; Alexandrov AV
    J Neurol; 2017 Jun; 264(6):1227-1235. PubMed ID: 28550481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram to Predict Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in Asian Population.
    Xie X; Yang J; Ren L; Hu S; Lian W; Xiao J; Pan L; Deng L; Ma J
    Curr Neurovasc Res; 2021; 18(5):543-551. PubMed ID: 34951382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperdense middle cerebral artery sign and response to combination of mechanical Thrombectomy plus intravenous thrombolysis in acute stroke patients.
    Mowla A; Razavi SM; Lail NS; Mohammadi P; Shirani P; Kavak KS; Sawyer RN; Kamal H
    J Neurol Sci; 2021 Oct; 429():117618. PubMed ID: 34418800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary Prestroke Dual Antiplatelet Use and Symptomatic Intracerebral Hemorrhage Risk After Thrombolysis.
    Peng TJ; Schwamm LH; Fonarow GC; Hassan AE; Hill M; Messé SR; Coronado F; Falcone GJ; Sharma R
    JAMA Neurol; 2024 Jul; 81(7):722-731. PubMed ID: 38767894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.
    Zand R; Tsivgoulis G; Sadighi A; Singh M; McCormack M; Shahjouei S; Goyal N; Noorbakhsh-Sabet N; Alexandrov AW; Alexandrov AV
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):620-624. PubMed ID: 29100859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiplatelet pretreatment on platelet aggregation and clinical outcomes in acute ischemic stroke patients treated with recombinant tissue-type plasminogen activator.
    Jing H; Yi-Jia G; -Bai-Li S; Ya-Peng L; Yu-Qiao Z; Cong G; -Li HJ; -Jun ZJ; Jie Y
    Pharmazie; 2020 Jan; 75(1):23-26. PubMed ID: 32033629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual antiplatelet therapy after intravenous thrombolysis for patients with minor ischemic stroke：A meta-analysis.
    Zeng J; Xin W; Tang S; Xiang C; Zeng C
    Clin Neurol Neurosurg; 2024 Mar; 238():108176. PubMed ID: 38417246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior use of antiplatelet therapy can be associated with a higher chance for early recanalization of the occluded middle cerebral artery in acute stroke patients treated with intravenous thrombolysis.
    Saňák D; Kuliha M; Herzig R; Roubec M; Skoloudík D; Zapletalová J; Köcher M; Král M; Veverka T; Cecháková E; Bártková A; Procházka V; Kaňovský P
    Eur Neurol; 2012; 67(1):52-6. PubMed ID: 22156368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of functional outcome after symptomatic intracranial hemorrhage complicating intravenous thrombolysis: results from the SITS-ISTR.
    Tsivgoulis G; Palaiodimou L; Stefanou MI; Theodorou A; Kõrv J; Nunes AP; Candelaresi P; Dall'Ora E; Sariaslani P; Provinciali L; Conforto AB; Cidrao AAL; Karapanayiotides T; Ahmed N
    Eur J Neurol; 2023 Oct; 30(10):3161-3171. PubMed ID: 37410547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.